ePRO-NOW: Study Build Application
On-time, error-free ePRO configuration
The ePRO-NOW Study Build Application is a revolutionary way to create on-time, error-free ePRO solutions for multiple platforms such as smartphone, tablet, web and sms.
A product of Arrowhead Electronic Healthcare's Reliability Engineering, ePRO-NOW was built to eliminate common points of failure in typical ePRO solutions including requirements errors, software programming errors, manual testing errors, translation errors, and project delays.
Key Functionality:
Study Design Module
- Non-software programmers can build complete ePRO studies
- Visual form design editor similar to Photoshop
- Single system for smartphone, tablet, web and sms
- Library of re-usable questionnaires, forms, buttons, and images
- Easy-to-use logic editor suitable for most ePRO studies. Custom code interface for use in highly complex studies
- Full language and locale capability
- Press "run" at any time during the design process to operate a live web version of your ePRO solution
- Generates validated code that creates real-time ePRO for Web. Code for smartphone and tablet is generated then loaded by Arrowhead onto devices
Study Specifications Module
- Integrated study specifications module for efficiency and control
- Export from web to .PDF
- Screen flow diagram generation and exporting
- Versioning and document control
- Change log
- Approvals
Software Testing Module
- Automated code generation and library function eliminates the source of most configuration errors
- Visual, run-time designer speeds up testing cycles
- A virtual army of dumb monkeys test and document each possible navigation path
- Automated generation of translation verification documentation
General Functionality
- Web-based system for global collaboration and scalability
- Easy-to-use navigation tree to help each team manage multiple programs, studies, questionnaires and forms
- Authenticated access is provided to selected functionality based on rights and roles
- Validated for regulatory requirements for use in global clinical trials
